Living donor and split-liver transplants in hepatitis C recipients: Does liver regeneration increase the risk for recurrence?

American Journal of Transplantation

Volumn 5, Issue 2, 2005, Pages 399-405

  Humar, Abhinav ^a   Horn, Kirsten ^a   Kalis, Ann ^a   Glessing, Brooke ^a   Payne, William D ^a   Lake, John ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Hepatitis C recurrence; Living donor liver; Protocol biopsy; Regeneration; Risk factors; Split livers

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; ISCHEMIA; LIVER BIOPSY; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; SPLIT LIVER TRANSPLANTATION; SURGICAL TECHNIQUE; SURVIVAL; TUMOR RECURRENCE;

ADULT; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C; HUMANS; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; RECURRENCE; RISK FACTORS;

EID: 13144258749     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00704.x     Document Type: Article

References (22)

1. Rosen HR. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis 2000; 20: 465-480.
2. Davis GL. New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation. Liver Transpl 2003; 9: S114-S119.
3. Braun M, Vierling JM. The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host. Liver Transpl 2003; 9: S79-S89.
4. Teixeira R, Papatheodoridis GV, Burroughs AK. Management of recurrent hepatitis C after liver transplantation. J Viral Hepat 2001; 8: 159-168.
5. Roayaie S, Schiano TD, Thung SN et al. Results of retransplantation for recurrent hepatitis C. Hepatology 2003; 38: 1428-1436.
6. Burroughs AK. Posttransplantation prevention and treatment of recurrent hepatitis C. Liver Transpl 2000; 6: S35-S40
7. Gaglio PJ, Malireddy S, Levitt BS et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003; 9: 1028-1035.
8. Troppmann C, Rossaro L, Perez RV, McVicar JP. Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation. Am J Transplant 2003; 3: 239-240
9. Zimmerman MA, Trotter JF. Living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S52-S57.
10. Humar A, Khwaja K, Sielaff TD, Lake JR, Payne WD. Technique of split-liver transplant for two adult recipients. Liver Transpl 2002; 8: 725-729.
11. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
12. Sheiner PA. Hepatitis C after liver transplantation. Semin Liver Dis 2000; 20: 201-209.
13. Chopra KB, Demetris AJ, Blakolmer K et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003; 76: 1487-1491.
14. Thomas RM, Brems JJ, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel DH. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl 2003; 9: 905-915.
15. Machicao VI, Bonatti H, Krishna M et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84-92.
16. Berenguer M. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 2003; 9: S44-S47.
17. Bahra M, Neumann UP, Harren M et al. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage. Transplant Proc 2002; 34: 2934-2935.
18. Sugo H, Balderson GA, Crawford DH et al. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today 2003; 33: 421-425.
19. Gaglio PJ, Malireddy S, Levitt BS et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003; 9: 1028-1035.
20. Everson GT, Trotter J. Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S64-S68.
21. Rodriguez-Luna H, Vargas HE, Sharma P et al. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004; 49: 38-41.
22. Bozorgzadeh A, Jain A, Ryan C et al. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004; 77: 1066-1070.